FAST and Furious About Quality: Impact of Continuous Review and Feedback on Point-of-Care Ultrasound Examinations von Reis, Nicholas C., Handspiker, Erin A., Bauerle, Wayne B., Reese, Vanessa, Benton, Adam J., Castillo, Roberto C., Robins, Lisa K., Ramirez, Christine L., Braverman, Maxwell A., Thomas, Peter G.

Volltext

Treatment for Mild Chronic Hypertension during Pregnancy von Tita, Alan T., Szychowski, Jeff M., Boggess, Kim, Dugoff, Lorraine, Sibai, Baha, Lawrence, Kirsten, Hughes, Brenna L., Bell, Joseph, Aagaard, Kjersti, Edwards, Rodney K., Gibson, Kelly, Haas, David M., Plante, Lauren, Metz, Torri, Casey, Brian, Esplin, Sean, Longo, Sherri, Hoffman, Matthew, Saade, George R., Hoppe, Kara K., Foroutan, Janelle, Tuuli, Methodius, Owens, Michelle Y., Simhan, Hyagriv N., Frey, Heather, Rosen, Todd, Palatnik, Anna, Baker, Susan, August, Phyllis, Reddy, Uma M., Kinzler, Wendy, Su, Emily, Krishna, Iris, Nguyen, Nicki, Norton, Mary E., Skupski, Daniel, El-Sayed, Yasser Y., Ogunyemi, Dotum, Galis, Zorina S., Harper, Lorie, Ambalavanan, Namasivayam, Geller, Nancy L., Oparil, Suzanne, Cutter, Gary R., Andrews, William W.

Volltext

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02 von Lee, Eudocia Q, Kuhn, John, Lamborn, Kathleen R, Abrey, Lauren, DeAngelis, Lisa M, Lieberman, Frank, Robins, H Ian, Chang, Susan M, Yung, W K Alfred, Drappatz, Jan, Mehta, Minesh P, Levin, Victor A, Aldape, Kenneth, Dancey, Janet E, Wright, John J, Prados, Michael D, Cloughesy, Timothy F, Gilbert, Mark R, Wen, Patrick Y

Volltext

Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study von DE GROOT, John F, LAMBORN, Kathleen R, MEHTA, Minesh P, LASSMAN, Andrew B, DEANGELIS, Lisa M, YUNG, W. K. Alfred, CHEN, Alice, PRADOS, Michael D, WEN, Patrick Y, CHANG, Susan M, GILBERT, Mark R, CLOUGHESY, Timothy F, ALDAPE, Kenneth, JUN YAO, JACKSON, Edward F, LIEBERMAN, Frank, ROBINS, H. Ian

Volltext

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas von Lamborn, Kathleen R, Yung, W K Alfred, Chang, Susan M, Wen, Patrick Y, Cloughesy, Timothy F, DeAngelis, Lisa M, Robins, H Ian, Lieberman, Frank S, Fine, Howard A, Fink, Karen L, Junck, Larry, Abrey, Lauren, Gilbert, Mark R, Mehta, Minesh, Kuhn, John G, Aldape, Kenneth D, Hibberts, Janelle, Peterson, Pamela M, Prados, Michael D

Volltext

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico von Dunkle, Lisa M, Kotloff, Karen L, Gay, Cynthia L, Áñez, Germán, Adelglass, Jeffrey M, Barrat Hernández, Alejandro Q, Harper, Wayne L, Duncanson, Daniel M, McArthur, Monica A, Florescu, Diana F, McClelland, R. Scott, Garcia-Fragoso, Veronica, Riesenberg, Robert A, Musante, David B, Fried, David L, Safirstein, Beth E, McKenzie, Mark, Jeanfreau, Robert J, Kingsley, Jeffrey K, Henderson, Jeffrey A, Lane, Dakotah C, Ruíz-Palacios, Guillermo M, Corey, Lawrence, Neuzil, Kathleen M, Coombs, Robert W, Greninger, Alex L, Hutter, Julia, Ake, Julie A, Smith, Katherine, Woo, Wayne, Cho, Iksung, Glenn, Gregory M, Dubovsky, Filip

Volltext

An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway von Guo, Deliang, Reinitz, Felicia, Youssef, Mary, Hong, Cynthia, Nathanson, David, Akhavan, David, Kuga, Daisuke, Amzajerdi, Ali Nael, Soto, Horacio, Zhu, Shaojun, Babic, Ivan, Tanaka, Kazuhiro, Dang, Julie, Iwanami, Akio, Gini, Beatrice, Dejesus, Jason, Lisiero, Dominique D, Huang, Tiffany T, Prins, Robert M, Wen, Patrick Y, Robins, H Ian, Prados, Michael D, Deangelis, Lisa M, Mellinghoff, Ingo K, Mehta, Minesh P, James, C David, Chakravarti, Arnab, Cloughesy, Timothy F, Tontonoz, Peter, Mischel, Paul S

Volltext

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors von Vivanco, Igor, Robins, H Ian, Rohle, Daniel, Campos, Carl, Grommes, Christian, Nghiemphu, Phioanh Leia, Kubek, Sara, Oldrini, Barbara, Chheda, Milan G, Yannuzzi, Nicolas, Tao, Hui, Zhu, Shaojun, Iwanami, Akio, Kuga, Daisuke, Dang, Julie, Pedraza, Alicia, Brennan, Cameron W, Heguy, Adriana, Liau, Linda M, Lieberman, Frank, Yung, W K Alfred, Gilbert, Mark R, Reardon, David A, Drappatz, Jan, Wen, Patrick Y, Lamborn, Kathleen R, Chang, Susan M, Prados, Michael D, Fine, Howard A, Horvath, Steve, Wu, Nian, Lassman, Andrew B, DeAngelis, Lisa M, Yong, William H, Kuhn, John G, Mischel, Paul S, Mehta, Minesh P, Cloughesy, Timothy F, Mellinghoff, Ingo K

Volltext

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis von Nissen, Steven E, Yeomans, Neville D, Solomon, Daniel H, Lüscher, Thomas F, Libby, Peter, Husni, M. Elaine, Graham, David Y, Borer, Jeffrey S, Wisniewski, Lisa M, Wolski, Katherine E, Wang, Qiuqing, Menon, Venu, Ruschitzka, Frank, Gaffney, Michael, Beckerman, Bruce, Berger, Manuela F, Bao, Weihang, Lincoff, A. Michael

Volltext

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes von Herold, Kevan C, Bundy, Brian N, Long, S. Alice, Bluestone, Jeffrey A, DiMeglio, Linda A, Dufort, Matthew J, Gitelman, Stephen E, Gottlieb, Peter A, Krischer, Jeffrey P, Linsley, Peter S, Marks, Jennifer B, Moore, Wayne, Moran, Antoinette, Rodriguez, Henry, Russell, William E, Schatz, Desmond, Skyler, Jay S, Tsalikian, Eva, Wherrett, Diane K, Ziegler, Anette-Gabriele, Greenbaum, Carla J

Volltext

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension von Humbert, Marc, Kovacs, Gabor, Hoeper, Marius M, Badagliacca, Roberto, Berger, Rolf M F, Brida, Margarita, Carlsen, Jørn, Coats, Andrew J S, Escribano-Subias, Pilar, Ferrari, Pisana, Ferreira, Diogenes S, Ghofrani, Hossein Ardeschir, Giannakoulas, George, Kiely, David G, Mayer, Eckhard, Meszaros, Gergely, Nagavci, Blin, Olsson, Karen M, Pepke-Zaba, Joanna, Quint, Jennifer K, Rådegran, Göran, Simonneau, Gerald, Sitbon, Olivier, Tonia, Thomy, Toshner, Mark, Vachiery, Jean Luc, Vonk Noordegraaf, Anton, Delcroix, Marion, Rosenkranz, Stephan

Volltext

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy von Raizer, Jeffrey J., Abrey, Lauren E., Lassman, Andrew B., Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Aldape, Kenneth A., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Lieberman, Frank, Cloughesy, Timothy F., Robins, H. Ian, Dancey, Janet, Prados, Michael D.

Volltext

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy von Guo, Deliang, Prins, Robert M, Dang, Julie, Kuga, Daisuke, Iwanami, Akio, Soto, Horacio, Lin, Kelly Y, Huang, Tiffany T, Akhavan, David, Hock, M Benjamin, Zhu, Shaojun, Kofman, Ava A, Bensinger, Steve J, Yong, William H, Vinters, Harry V, Horvath, Steve, Watson, Andrew D, Kuhn, John G, Robins, H Ian, Mehta, Minesh P, Wen, Patrick Y, DeAngelis, Lisa M, Prados, Michael D, Mellinghoff, Ingo K, Cloughesy, Timothy F, Mischel, Paul S

Volltext

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? von Clarke†, Jennifer L., Ennis†, Michele M., Yung, W. K. Alfred, Chang, Susan M., Wen, Patrick Y., Cloughesy, Timothy F., DeAngelis, Lisa M., Robins, H. Ian, Lieberman, Frank S., Fine, Howard A., Abrey, Lauren, Gilbert, Mark R., Mehta, Minesh, Kuhn, John G., Aldape, Kenneth D., Lamborn, Kathleen R., Prados, Michael D.

Volltext

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme von Chang, Susan M, Wen, Patrick, Cloughesy, Timothy, Greenberg, Harry, Schiff, David, Conrad, Charles, Fink, Karen, Robins, H Ian, De Angelis, Lisa, Raizer, Jeffrey, Hess, Kenneth, Aldape, Ken, Lamborn, Kathleen R, Kuhn, John, Dancey, Janet, Prados, Michael D

Volltext

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08) von Wen, Patrick Y, Yung, W K Alfred, Lamborn, Kathleen R, Norden, Andrew D, Cloughesy, Timothy F, Abrey, Lauren E, Fine, Howard A, Chang, Susan M, Robins, H Ian, Fink, Karen, Deangelis, Lisa M, Mehta, Minesh, Di Tomaso, Emmanuelle, Drappatz, Jan, Kesari, Santosh, Ligon, Keith L, Aldape, Ken, Jain, Rakesh K, Stiles, Charles D, Egorin, Merrill J, Prados, Michael D

Volltext

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma von Norden, Andrew D., Raizer, Jeffrey J., Abrey, Lauren E., Lamborn, Kathleen R., Lassman, Andrew B., Chang, Susan M., Yung, W. K. Alfred, Gilbert, Mark R., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Cloughesy, Timothy F., Robins, H. Ian, Aldape, Kenneth, Dancey, Janet, Prados, Michael D., Lieberman, Frank, Wen, Patrick Y.

Volltext

Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consort... von CLOUGHESY, Timothy F, WEN, Patrick Y, LIEBERMAN, Frank, KUHN, John, DEANGELIS, Lisa M, MEHTA, Minesh, RAIZER, Jeff J, ALFRED YUNG, W. K, ALDAPE, Ken, WRIGHT, John, LAMBORN, Kathleen R, PRADOS, Michael D, IAN ROBINS, H, CHANG, Susan M, GROVES, Morris D, FINK, Karen L, JUNCK, Larry, SCHIFF, David, ABREY, Lauren, GILBERT, Mark R

Volltext

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure von Tang, Anthony S.L, Wells, George A, Talajic, Mario, Arnold, Malcolm O, Sheldon, Robert, Connolly, Stuart, Hohnloser, Stefan H, Nichol, Graham, Birnie, David H, Sapp, John L, Yee, Raymond, Healey, Jeffrey S, Rouleau, Jean L

Volltext

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema von Wells, John A, Glassman, Adam R, Ayala, Allison R, Jampol, Lee M, Aiello, Lloyd Paul, Antoszyk, Andrew N, Arnold-Bush, Bambi, Baker, Carl W, Bressler, Neil M, Browning, David J, Elman, Michael J, Ferris, Frederick L, Friedman, Scott M, Melia, Michele, Pieramici, Dante J, Sun, Jennifer K, Beck, Roy W

Volltext